Creating a comprehensive and efficient product launch ecosystem that seamlessly addresses all mission critical business needs while optimizing costs and promoting synergy throughout all integrated commercialization elements.
Our System
U.S. Pharma Consulting (USPC) is a highly specialized consulting firm offering Pharma, MedTech, and Biotech expertise supported by AI services for your product portfolio business solution needs.
Expertise at it’s finest
USPC is proud to offer array of comprehensive U.S. pharmaceutical industry services with expertise in Rx product commercialization – BLA, 505(b)(1), 505(b)(2), 505(j), 510(k),503(a)(b):
Areas of focus – full real time commercialization and regulatory experience for brand Rx pharmaceuticals, generic Rx pharmaceuticals, authorized generics.
Our other areas of focus include animal health [Green Book Drugs—NADA, ANADA, CNADA], MedTech [510(k), 513(f)(2) DeNovo, PMA] and OTC drugs.
Our primary business focus is molecules or device to market and most importantly the market back to molecule or device.
USPC offers pharmaceutical and med tech consulting services including C-suite business relationships, experience and expertise including but not limited to company/product commercialization, CDMO, clinical, API, regulatory (FDA pathways), legal/patent (FDA), manufacturing pre-audit inspection, technical transfer – (CBE-30, PAS), U.S. agent - customs, sales, marketing specialty pharmacy, managed markets, 3PL logistics, state license strategies, drug compendium, supply chain, trade operations, product and market analysis, go to market readiness and strategies, HUB services, marketing and touch all points of distribution (government, wholesalers, retail, hospital, GPO - hospital, mail order).
Areas of focus – full real time commercialization and regulatory experience for brand Rx pharmaceuticals, generic Rx pharmaceuticals, authorized generics.
Our other areas of focus include animal health [Green Book Drugs—NADA, ANADA, CNADA], MedTech [510(k), 513(f)(2) DeNovo, PMA] and OTC drugs.
Our primary business focus is molecules or device to market and most importantly the market back to molecule or device.
USPC offers pharmaceutical and med tech consulting services including C-suite business relationships, experience and expertise including but not limited to company/product commercialization, CDMO, clinical, API, regulatory (FDA pathways), legal/patent (FDA), manufacturing pre-audit inspection, technical transfer – (CBE-30, PAS), U.S. agent - customs, sales, marketing specialty pharmacy, managed markets, 3PL logistics, state license strategies, drug compendium, supply chain, trade operations, product and market analysis, go to market readiness and strategies, HUB services, marketing and touch all points of distribution (government, wholesalers, retail, hospital, GPO - hospital, mail order).
See what our clients are saying about USPC
"U.S. Pharma Consulting (USPC) has been an innovative partner in the development of our generic pharmaceutical manufacturing business in the USA. Their depth of knowledge of the commercialization and extensive contacts has allowed us to establish a foothold in the very complex marketplace. USPC provided timely guidance in the launch of our strong distribution platform that will pay dividends in years to come. Working together with USPC, we expect to become a thriving business in the USA and numerous Global Markets."
President - Generic Manufacture
"U.S. Pharma Consulting (USPC) has been an innovative partner in the development of our generic pharmaceutical manufacturing business in the USA. Their depth of knowledge of the commercialization and extensive contacts has allowed us to establish a foothold in the very complex marketplace. USPC provided timely guidance in the launch of our strong distribution platform that will pay dividends in years to come. Working together with USPC, we expect to become a thriving business in the USA and numerous Global Markets."
President - Generic Manufacture
USPC Commitment
USPC offers real-time U.S. market Pharma solutions by maintaining strong business relationships with key decision-makers involved in FDA drug development, manufacturing, delivery (distribution), and reimbursement (payers) of healthcare pharmaceutical and Medtech products.
“There is one constant in the U.S. healthcare market, changes happen, and every business needs a strategic plan.” USPC is ready to assist your real-time and future business solution plans.
Let's get started with your free consultation “There is one constant in the U.S. healthcare market, changes happen, and every business needs a strategic plan.” USPC is ready to assist your real-time and future business solution plans.